"The Joslin Diabetes Center at the SUNY Upstate Medical University in Syracuse opened in 1995 and provides care to the largest number of patients with diabetes of any center in Central New York. Here specialists in endocrinology, diabetes and metabolism care for patients with disorders of the major glands of the body, diabetes, osteoporosis, and other metabolic diseases. An internationally recognized leader in diabetes treatment, research, and education, the Joslin Diabetes Center is affiliated with Harvard Medical School and has been caring for the medical and emotional needs of people with diabetes since it was founded in 1898."

During the past decade, Joslin Diabetes Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Joslin Diabetes Center" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Joslin Diabetes Center" are "Diabetes" (1 trials), "Type 1 Diabetes" (1 trials) and "Type 1 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Joslin Diabetes Center" in a lesser frequency.

Most popular intervention types in "Joslin Diabetes Center" are "Device" (2 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Medtronic (NO LGS FEATURE ) using Paradigm® Revel™2.0 Pump" (1 trials), "Medtronic MMT-754 Veo Insulin pump testing Low Glucose Suspend (LGS) feature" (1 trials), "Medtronic MiniMed 530G Insulin Pump" (1 trials), "Placebo" (1 trials) and "Teplizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Joslin Diabetes Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Joslin Diabetes Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Joslin Diabetes Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Joslin Diabetes Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".